Is this email not displaying correctly?
View it in your browser.

Fall 2014


 
Dr. Nadeau

Dear Friend,

This special edition of Stanford Allergy Center News features three articles by noted author Melanie Thernstrom—best known in the allergy community for her New York Times Magazine article, "The Allergy Buster."

Melanie's promising report on two new blood tests in development at Stanford will open your eyes to the highly predictive food allergy diagnostics that are on the horizon. She also leads an engaging discussion on food allergies and immunology with Stanford School of Medicine's Dean Minor, and takes us to the heart of Stanford Allergy Center's patient care experience in a just published Stanford Medicine Magazine article about the world's first multiple food allergen oral immunotherapy trials.  

As Stanford continues to make great strides in food allergy therapies and diagnostics, we encourage you this share this issue with friends and family affected by allergies.

Spotlight

 
Dean MinorDean Minor
Stanford School of Medicine's Dean Minor discusses food allergies, immunology and the establishment of Stanford's new Allergy Center in this conversation with author Melanie Thernstrom.


 
 
Kieran"I Can Eat It"
Melanie Thernstrom takes us on the journey of three young patients who participated in the world’s first multiple food allergen oral immunotherapy trials conducted at Stanford. Published in Stanford Medicine Magazine.

Stanford Allergy Research 

Better Blood Tests 
Newborn FeetTwo new food allergy diagnostics in development at Stanford measure reactivity to 90 allergens with just a few drops of blood, even in newborns! Learn more about these highly predictive, experimental blood tests in this article by Melanie Thernstrom.

Upcoming Events

Stanford Allergy Center Talk: October 27
Dr. Nadeau at TalkStanford Allergy Center team members will discuss recent advancements in food allergy research in this educational talk. This event is currently full, but we encourage you to put your name on our waitlist as seats tend to open up.

Informational Meeting: November 6
If you are an adult with a diagnosed peanut allergy, we invite you to attend an informational meeting led by Dr. Kari Nadeau on our upcoming Peanut Oral Immunotherapy: Safety, Efficacy and Discovery Study (POISED). Learn more about this trial, currently enrolling adult participants ages 18-55. RSVP here.

Get Involved!

Share Stanford Allergy Center News with friends and family affected by allergies.

Join our Community to receive Stanford Allergy Center News and stay abreast of Stanford's emerging therapies, research, and diagnostics.

Follow us on Facebook for up-to-the-minute updates on allergy research developments at Stanford.

What's New

Jeff and MacKenzie Bezos Extend $2.25 Million Challenge Grant 
Jeff and MacKenzie Bezos extend a $2.25 million challenge grant to fund innovative clinical food allergy research at Stanford. “Dr. Nadeau and her team are transforming food allergy research,” says Jeff Bezos. “MacKenzie and I are optimistic that they will continue to achieve breakthroughs and improve the lives of allergy patients.” Read press release

CA Stock Epinephrine Bill Signed into Law
Last month, Governor Jerry Brown signed California stock epinephrine bill SB1266 into law. The bill, which will go into effect on January 1, will protect children and adults with undiagnosed allergies who have an anaphylactic reaction at school. Thank you for supporting this important bill!

Pictured: Stanford Allergy Center Community Council members Roscio Miscio, Sharon Wong, and Caroline Chen with California Senator Bob Huff, after testifying in support of SB1266.
Pictured: Stanford Allergy Center Community Council members Roscio Miscio, Sharon Wong, and Caroline Chen with California Senator Bob Huff, after testifying in support of SB1266. 

Clinical Trials

Stanford Enrolling Adults in Peanut OIT Study
Stanford is currently enrolling adults ages 18-55 in its Peanut Oral Immunotherapy: Safety, Efficacy and Discovery Study (POISED). If you are interested in being screened for this trial, please send us an email. To find out more details on the trial, including inclusion and exclusion criteria, please click here.

Doses 
Oral Immunotherapy Dose 

Upon completion of the trial, you will be offered state of the art immunotherapy treatment for all your other allergies as part of your continuing care at our Allergy Center. 

Matching Gift Challenge

Consider a year-end gift in support of food allergy research at Stanford University School of Medicine and Lucile Packard Children’s Hospital Stanford. When you make a contribution today your gift will double in value and impact through a matching gift grant established by Jeff and MacKenzie Bezos. 

The Center also welcomes tax-deductible gifts in kind in the form of electronic devices or furniture (desks, armchairs, or desk chairs). Please contact us if you or your business would like to make such a contribution. 
 

Melanie ThernstromMelanie Thernstrom is a contributing writer to The New York Times Magazine and the author of three books including, most recently, The New York Times bestseller The Pain ChroniclesCures, Myths, Mysteries, Prayers, Diaries, Brain Scans, and the Science of Suffering.

 
Friend on Facebook Follow us on Facebook
(c) 2014 This newsletter is sent on behalf of the Stanford Allergy Center. To opt out of future online communications from the Center, please follow the instructions in the footer of this email.